Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-23
2005-08-23
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S114000, C546S115000, C546S113000, C514S300000, C514S302000
Reexamination Certificate
active
06933306
ABSTRACT:
Pharmacologically active compounds are provided as well as pharmaceutical compositions and methods for treating cancer; inflammation; an autoimmune, infectious or ocular disease; or age-related macular degeneration in a mammal.
REFERENCES:
patent: 6469020 (2002-10-01), Batty et al.
patent: 6734189 (2004-05-01), Batty et al.
patent: 0780386 (1996-12-01), None
patent: WO 9724117 (1997-01-01), None
patent: WO 9805635 (1997-08-01), None
patent: WO 9924399 (1998-11-01), None
patent: WO 0012477 (1999-08-01), None
patent: WO 0012478 (1999-08-01), None
Orazi, O. et al. “Synthesis of Fused Heterocycles: 1, 2, 3, 4-Tetrahydroisoquinolines and Ring Homologues via Sulphonamidomethylation”J. Chem. Soc. Perkin Trans.1(11):1977-1982.
Baxter Andrew Douglas
Dyke Hazel Joan
Hannah Duncan Robert
Keily John Fraser
Watson Robert John
Aulakh Charanjit S.
Darwin Discovery Ltd.
Saliwanchik Lloyd & Saliwanchik
LandOfFree
Hydroxamic and carboxylic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxamic and carboxylic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamic and carboxylic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3476071